Hydronephrosis Market Research Report - Forecast Till 2030

Hydronephrosis Market Information: By Type (Unilateral, Bilateral), Diagnosis (Laboratory Tests, Imaging), Treatment (Shock Wave Lithotripsy, Laparoscopy, Bladder Catheterization, Steroid Therapy), And Indication (Intrinsic, Extrinsic) - Forecast Till 2030

ID: MRFR/Pharma/2879-HCR | February 2023 | Region: Global | 206 Pages         

Hydronephrosis Market Speak to Analyst Request a Free Sample

Hydronephrosis Market Scenario


The Hydronephrosis Market is anticipated to reach USD 388.4 Million by 2030 at 12.2% CAGR during the forecast period 2022-2030.


Hydronephrosis is a condition characterized by a swollen kidney as a result of abnormal drainage of urine from the kidney to the bladder. It is a secondary disease that results from primary disease that may affect the kidney. Symptoms of hydronephrosis includes fever, pain when urinating, nausea or vomiting, and pain in the abdomen. It may be unilateral or bilateral. Unilateral hydronephrosis is swelling  of one kidney, whereas, bilateral hydronephrosis is swelling of both the kidneys. Hydronephrosis is mostly diagnosed through ultrasound examination.


Hydronephrosis has become a major problem across the globe due to rising prevalence of kidney diseases, lack of awareness about the diseases and their treatment, which favor the growth of the market. Rising prevalence of kidney diseases especially, in the geriatric population and availability of cost-effective treatment propel the market growth.


FIGURE 1 Global Hydronephrosis Market by Diagnosis, 2016 (%) Hydronephrosis Market


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company PresentationKey Players in the Hydronephrosis Market                                         Some of the key players in hydronephrosis market are NephroGenex, Inc. (U.S), American Renal Associates (U.S), PHRAXIS, INC. (U.S), Renal Associates P.A. (U.S), ALLERGAN (U.S), Amgen Inc. (U.S), Anthem Bio Pharm (U.S), Sanofi (U.S), and Novartis AG (Germany)   .


Segments The hydronephrosis market is segmented on the basis of types, which includes unilateral hydronephrosis and bilateral hydronephrosis.


On the basis of diagnosis, the hydronephrosis market is segmented into laboratory test and imaging. Laboratory test is further segmented into urinalysis, Complete Blood Count (CBC), electrolyte analysis, and others. Imaging is further sub-segmented into CT scan, ultrasound, intravenous pyelography, KUB X-rays, and others.


On the basis of treatment, the hydronephrosis market is segmented into shock wave lithotripsy, laparoscopy, bladder catheterization, steroid therapy, and others.


On the basis of indication the hydronephrosis market is segmented into intrinsic and extrinsic causes of hydronephrosis. The intrinsic causes are further sub-segmented into acute unilateral obstructive uropathy, kidney stone, bladder cancer, bladder stones, cystocele, urethral stricture, urethral cancer and others. The extrinsic causes are further sub-segmented into retroperitoneal fibrosis, ovarian vein syndrome, cancer of the cervix, cancer of the prostate, uterine prolapse, prostate cancer, and others.


Research Methodology Hydronephrosis Market-


Source: World Health Organization, Centers for Disease Control and Prevention, European Society of Clinical Microbiology and Infectious Diseases, U.S. National Library of Medicine, National Organization for Rare Disorders, The American Autoimmune Related Diseases Association, The International Society for Human and Animal Mycology, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Regional Analysis of the Hydronephrosis Market           The American region accounted for the largest share of the global market due to increasing prevalence of chronic kidney diseases, and rising demand for diagnosis and treatment of hydronephrosis. Hydronephrosis are leading urological diseases in the U.S. According to the Center for Diseases Control and Prevention, 48,146 deaths occurred due to nephrosis and kidney diseases in the year 2014. It also stated that the number of adults diagnosed with kidney diseases in 2014 was 4.9 million in the US.


Europe is the second largest market that holds a noticeable share of the hydronephrosis market. According to the European database for surveillance of congenital malformations report, hydronephrosis is prevalence among new born and pregnant women.


In Asia Pacific, rising prevalence of kidney stone, rising geriatric population and growing demand for counselling about hydronephrosis drive the market growth. 


The Middle East & Africa is expected to show a steady growth in this market due constant demand for diagnostics devices, awareness about maternal and child health in most of the African countries and the government efforts to cater primary health need of the population.The report on the hydronephrosis market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The hydronephrosis market report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions. Intended Audience



  • Medical Device Manufacturers

  • Medical Device Suppliers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors



Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 388.4 Million
  CAGR   12.2% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Diagnosis, Treatment, Indication
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   NephroGenex, Inc. (U.S), American Renal Associates (U.S), PHRAXIS, INC. (U.S), Renal Associates P.A. (U.S), ALLERGAN (U.S), Amgen Inc. (U.S), Anthem Bio Pharm (U.S), Sanofi (U.S), and Novartis AG (Germany)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Rising prevalence of kidney diseases
  • Lack of awareness about the diseases and their treatment


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Hydronephrosis market is projected to grow at a 12.2% CAGR between 2022- 2030.

    The Americas is expected to dominate the hydronephrosis market.

    Hydronephrosis market is predicted to touch USD 388.4 Million by 2030.

    Rising prevalence of kidney disease and availability of cost-effective treatment are the key factors driving the hydronephrosis market.

    Notable players profiled in the hydronephrosis market include Novartis AG (Germany), Sanofi (U.S), Anthem Bio Pharm (U.S), Amgen Inc. (U.S), ALLERGAN (U.S), Renal Associates P.A. (U.S), PHRAXIS, INC. (U.S), American Renal Associates (U.S), and NephroGenex, Inc. (U.S).